Matches in Wikidata for { <http://www.wikidata.org/entity/Q82032854> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- Q82032854 description "article scientifique (publié 2011)" @default.
- Q82032854 description "artikull shkencor i botuar më 01 janar 2011" @default.
- Q82032854 description "artículu científicu espublizáu en xineru de 2011" @default.
- Q82032854 description "scientific article published on 01 January 2011" @default.
- Q82032854 description "wetenschappelijk artikel" @default.
- Q82032854 description "наукова стаття, опублікована в січні 2011" @default.
- Q82032854 name "Phase III trial of irinotecan plus infusional 5-fluorouracil/folinic acid versus irinotecan plus oxaliplatin as first-line treatment of advanced colorectal cancer" @default.
- Q82032854 name "Phase III trial of irinotecan plus infusional 5-fluorouracil/folinic acid versus irinotecan plus oxaliplatin as first-line treatment of advanced colorectal cancer" @default.
- Q82032854 name "Phase III trial of irinotecan plus infusional 5-fluorouracil/folinic acid versus irinotecan plus oxaliplatin as first-line treatment of advanced colorectal cancer" @default.
- Q82032854 type Item @default.
- Q82032854 label "Phase III trial of irinotecan plus infusional 5-fluorouracil/folinic acid versus irinotecan plus oxaliplatin as first-line treatment of advanced colorectal cancer" @default.
- Q82032854 label "Phase III trial of irinotecan plus infusional 5-fluorouracil/folinic acid versus irinotecan plus oxaliplatin as first-line treatment of advanced colorectal cancer" @default.
- Q82032854 label "Phase III trial of irinotecan plus infusional 5-fluorouracil/folinic acid versus irinotecan plus oxaliplatin as first-line treatment of advanced colorectal cancer" @default.
- Q82032854 prefLabel "Phase III trial of irinotecan plus infusional 5-fluorouracil/folinic acid versus irinotecan plus oxaliplatin as first-line treatment of advanced colorectal cancer" @default.
- Q82032854 prefLabel "Phase III trial of irinotecan plus infusional 5-fluorouracil/folinic acid versus irinotecan plus oxaliplatin as first-line treatment of advanced colorectal cancer" @default.
- Q82032854 prefLabel "Phase III trial of irinotecan plus infusional 5-fluorouracil/folinic acid versus irinotecan plus oxaliplatin as first-line treatment of advanced colorectal cancer" @default.
- Q82032854 P1433 Q82032854-F2EFDBEF-1630-4C68-B682-A62DA2C66E9E @default.
- Q82032854 P1476 Q82032854-01AD7332-07E6-4ADE-9142-32BD66687324 @default.
- Q82032854 P2093 Q82032854-0531BD08-99EA-4131-9E14-AC564FFA50B1 @default.
- Q82032854 P2093 Q82032854-32EF79BC-0F42-487A-B4FA-FB4A78E25976 @default.
- Q82032854 P2093 Q82032854-463C8C80-D3C7-4F32-BBDA-F6BE2A98D3C2 @default.
- Q82032854 P2093 Q82032854-46FCF623-8CBD-4E71-AD34-AF32C9E85E14 @default.
- Q82032854 P2093 Q82032854-4786C94A-E0CD-4091-9E05-8B7EED174ED9 @default.
- Q82032854 P2093 Q82032854-4ABC406F-4731-4CFD-9451-712EFF24C113 @default.
- Q82032854 P2093 Q82032854-587F9B6C-CA7F-4004-BA8C-867A004CF681 @default.
- Q82032854 P2093 Q82032854-6EE50ED0-7DE6-4ADB-B61B-5CCB4F3ED64C @default.
- Q82032854 P2093 Q82032854-84FF4A6E-7788-4AB7-B83B-70B430B0497F @default.
- Q82032854 P2093 Q82032854-9DBCCC70-13D8-46ED-ADBD-32E754B2A36E @default.
- Q82032854 P2093 Q82032854-AE3009B7-2689-49F0-951C-0BC5C28F2C4C @default.
- Q82032854 P2093 Q82032854-AFF62BB8-25EB-49D9-B855-DC1DFE39C84C @default.
- Q82032854 P2093 Q82032854-B845DE34-5166-4DAE-BD3F-EBD5F4798DDE @default.
- Q82032854 P2093 Q82032854-B86EA91B-FEC8-418A-A107-547B40B1A4EA @default.
- Q82032854 P2093 Q82032854-CD2C62BB-74F8-4A21-BEB1-60C4FF50AA52 @default.
- Q82032854 P2093 Q82032854-D66EDFE5-5C61-4BBB-9689-CF81110FA51B @default.
- Q82032854 P2093 Q82032854-EE418C52-3F79-4AA6-9021-9849E5616C82 @default.
- Q82032854 P2093 Q82032854-F383F296-96CF-44F8-8B4B-86BF517C6423 @default.
- Q82032854 P2093 Q82032854-FE2EE5D9-4A68-4823-B5E1-2111BC3425BE @default.
- Q82032854 P304 Q82032854-0C13CFD7-75A3-4FB7-AE3B-E03E17B7318B @default.
- Q82032854 P31 Q82032854-55B0930C-4035-48F8-9B80-749A993E9CBE @default.
- Q82032854 P356 Q82032854-F3F3F581-0AA9-46FB-B7A3-DD5C6EF0E654 @default.
- Q82032854 P433 Q82032854-1540E3A3-3F01-4324-B142-241BC9BA745B @default.
- Q82032854 P478 Q82032854-3F5A80BB-1F58-4DFE-A931-5ECE2EB3882D @default.
- Q82032854 P50 Q82032854-895DB5B0-3604-4522-B1DE-0DE312B4D3CE @default.
- Q82032854 P577 Q82032854-C42633C6-E739-4307-A154-FDC0B04775B7 @default.
- Q82032854 P698 Q82032854-C3DF0EDD-5B44-488F-872D-EC5EA0CD970E @default.
- Q82032854 P921 Q82032854-1F733645-38C6-433D-BC90-E61F84E555F4 @default.
- Q82032854 P921 Q82032854-397E6957-785C-4D89-BF30-791D11137C6C @default.
- Q82032854 P921 Q82032854-45D8C6D3-FA40-4B0A-9DF4-11FE48385A58 @default.
- Q82032854 P921 Q82032854-71530FE6-4E06-4F71-8C2B-EA090C318FBC @default.
- Q82032854 P356 J.EJCA.2010.09.022 @default.
- Q82032854 P698 20971632 @default.
- Q82032854 P1433 Q332260 @default.
- Q82032854 P1476 "Phase III trial of irinotecan plus infusional 5-fluorouracil/folinic acid versus irinotecan plus oxaliplatin as first-line treatment of advanced colorectal cancer" @default.
- Q82032854 P2093 "Andreas Schalhorn" @default.
- Q82032854 P2093 "Borika Szukics" @default.
- Q82032854 P2093 "Clemens Giessen" @default.
- Q82032854 P2093 "Daniel Bosse" @default.
- Q82032854 P2093 "Daniel Oruzio" @default.
- Q82032854 P2093 "Detlef Quietzsch" @default.
- Q82032854 P2093 "Helmut Lambertz" @default.
- Q82032854 P2093 "Johann Mittermüller" @default.
- Q82032854 P2093 "Juergen Truckenbrodt" @default.
- Q82032854 P2093 "Karin Weigang-Köhler" @default.
- Q82032854 P2093 "Manfred Schulze" @default.
- Q82032854 P2093 "Marc Grundeis" @default.
- Q82032854 P2093 "Mariele Goebeler" @default.
- Q82032854 P2093 "Martina Stauch" @default.
- Q82032854 P2093 "Peter A Maubach" @default.
- Q82032854 P2093 "Rudolf Schlag" @default.
- Q82032854 P2093 "Thomas Zwingers" @default.
- Q82032854 P2093 "Ute Vehling-Kaiser" @default.
- Q82032854 P2093 "Volker Heinemann" @default.
- Q82032854 P304 "206-214" @default.
- Q82032854 P31 Q13442814 @default.
- Q82032854 P356 "10.1016/J.EJCA.2010.09.022" @default.
- Q82032854 P433 "2" @default.
- Q82032854 P478 "47" @default.
- Q82032854 P50 Q47158566 @default.
- Q82032854 P577 "2011-01-01T00:00:00Z" @default.
- Q82032854 P698 "20971632" @default.
- Q82032854 P921 Q188874 @default.
- Q82032854 P921 Q412197 @default.
- Q82032854 P921 Q422327 @default.
- Q82032854 P921 Q42824827 @default.